Prescription drug · ANDA
Potassium Chloride ER NDC 72189-462
Potassium chloride 1500 mg/1 · Tablet, Extended release · Oral · Direct_Rx
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 72189-462-30 | 72189046230 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (72189-462-30)Marketed from Apr 17, 2023 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Potassium Chloride ER
- Generic name (nonproprietary)
- potassium chloride er
- Active ingredients
- Potassium chloride — 1500 mg/1
- Dosage form
- Tablet, Extended release
- Route
- Oral
- Labeler
- Direct_Rx
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 203562
- Marketing start
- Listing expires
- Other FDA classes
- Increased Large Intestinal Motility (Physiologic effect)Inhibition Large Intestine Fluid/Electrolyte Absorption (Physiologic effect)Osmotic Activity (Mechanism)Potassium Compounds (Chemical structure)
- Identifiers
- Product ID 72189-462_2c4ddf50-4e21-7c59-e063-6294a90ace41SPL ID 2c4ddf50-4e21-7c59-e063-6294a90ace41SPL set ID f988aa11-60ef-411e-e053-6294a90a522aRxCUI 1801294UNII 660YQ98I10
- Pharmacologic class
- Osmotic Laxative; Potassium Salt
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N472189046230followed by a unit qualifier and the quantityPackage 72189-0462-30. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
BECAUSE OF REPORTS OF INTESTINAL AND GASTRIC ULCERATION AND BLEEDING WITH CONTROLLED-RELEASE POTASSIUM CHLORIDE PREPARATIONS, THESE DRUGS SHOULD BE RESERVED FOR THOSE PATIENTS WHO CANNOT TOLERATE OR REFUSE TO TAKE LIQUID OR EFFERVESCENT POTASSIUM PREPARATIONS OR FOR PATIENTS IN WHOM THERE IS A PROBLEM OF COMPLIANCE WITH THESE PREPARATIONS. 1. For the treatment of patients with hypokalemia with or without metabolic alkalosis, in digitalis intoxication, and in patients with hypokalemic familial periodic paralysis. If hypokalemia is the result of diuretic therapy, consideration should be given to the use of a lower dose of diuretic, which may be sufficient without leading to hypokalemia. 2. For…
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 203562
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| potassium chloride | Potassium chloride 1500 mg/1 | Tablet, Extended releaseOral | Redpharm Drug | 67296-2131 |
| potassium chloride | Potassium chloride 1500 mg/1 | Tablet, Extended releaseOral | Bryant Ranch Prepack | 71335-1109 |
| potassium chloride | Potassium chloride 1500 mg/1 | Tablet, Extended releaseOral | A-S Medication Solutions | 50090-7456 |
| potassium chloride | Potassium chloride 1500 mg/1 | Tablet, Extended releaseOral | A-S Medication Solutions | 50090-3700 |